![]() |
Name |
xylarialoid A
|
Molecular Formula | C29H33NO5 | |
IUPAC Name* |
4-ethenyl-21-hydroxy-9,11-dimethyl-15,23-dioxa-25-azaheptacyclo[19.2.2.216,19.13,7.01,22.08,13.014,28]octacosa-5,16(27),17,19(26)-tetraene-2,24-dione
|
|
SMILES |
C=CC1C=CC2C3CC(C)CC(C)C3C3Oc4ccc(cc4)CC4(O)NC(=O)C5(OC45)C(=O)C1C23
|
|
InChI |
InChI=1S/C29H33NO5/c1-4-17-7-10-19-20-12-14(2)11-15(3)21(20)24-23(19)22(17)25(31)29-26(35-29)28(33,30-27(29)32)13-16-5-8-18(34-24)9-6-16/h4-10,14-15,17,19-24,26,33H,1,11-13H2,2-3H3,(H,30,32)/t14-,15+,17-,19+,20+,21-,22+,23+,24-,26+,28-,29+/m1/s1
|
|
InChIKey |
MXGKGKHBWZRDGC-GBNUILQCSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 475.59 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 88.2 | Aromatic Rings: | 8 |
Heavy Atoms: | 35 | QED Weighted: | 0.366 |
Caco-2 Permeability: | -4.83 | MDCK Permeability: | 0.00019185 |
Pgp-inhibitor: | 0.627 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.047 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.142 | Plasma Protein Binding (PPB): | 97.95% |
Volume Distribution (VD): | 2.046 | Fu: | 2.24% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.89 |
CYP2C19-inhibitor: | 0.728 | CYP2C19-substrate: | 0.899 |
CYP2C9-inhibitor: | 0.316 | CYP2C9-substrate: | 0.037 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.247 |
CYP3A4-inhibitor: | 0.942 | CYP3A4-substrate: | 0.909 |
Clearance (CL): | 8.632 | Half-life (T1/2): | 0.031 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.063 |
Drug-inuced Liver Injury (DILI): | 0.951 | AMES Toxicity: | 0.342 |
Rat Oral Acute Toxicity: | 0.987 | Maximum Recommended Daily Dose: | 0.93 |
Skin Sensitization: | 0.035 | Carcinogencity: | 0.143 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.923 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005770 | ![]() |
0.726 | D0VA0I | ![]() |
0.224 | ||
ENC005769 | ![]() |
0.711 | D02FEM | ![]() |
0.199 | ||
ENC005767 | ![]() |
0.681 | D0W2EK | ![]() |
0.199 | ||
ENC005766 | ![]() |
0.636 | D06WTZ | ![]() |
0.193 | ||
ENC005366 | ![]() |
0.628 | D0H0ND | ![]() |
0.191 | ||
ENC003606 | ![]() |
0.628 | D0V3ZA | ![]() |
0.187 | ||
ENC005768 | ![]() |
0.591 | D06OMK | ![]() |
0.187 | ||
ENC003989 | ![]() |
0.557 | D01XDL | ![]() |
0.187 | ||
ENC003349 | ![]() |
0.474 | D0I5DS | ![]() |
0.186 | ||
ENC003137 | ![]() |
0.474 | D03IKT | ![]() |
0.184 |